This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Abstract A87: Preliminary results of a phase II study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer., Molecular Cancer Therapeutics, November 2011, American Association for Cancer Research (AACR),
DOI: 10.1158/1535-7163.targ-11-a87.
You can read the full text:
The following have contributed to this page
